Free Trial
→ Trump goes 'all-in' on Grand Canyon energy breakthrough (From Behind the Markets) (Ad)tc pixel
NASDAQ:AGPU

Axe Compute Q1 2026 Earnings Results & Report

Axe Compute logo
$7.68 -0.73 (-8.68%)
Closing price 04:00 PM Eastern
Extended Trading
$7.90 +0.22 (+2.86%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Axe Compute reported Q1 2026 earnings on May 15, 2026. The company reported EPS of -$0.36, while revenue was $0.04 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes

Axe Compute EPS Results

Actual EPS
-$0.36
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Axe Compute Revenue Results

Actual Revenue
$0.04 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Axe Compute Q1 2026 Earnings FAQ

Axe Compute (NASDAQ:AGPU) reported earnings of -$0.36 per share for Q1 2026. The report was announced on Friday, May 15, 2026.

Axe Compute reported revenue of $0.04 million for Q1 2026.

Axe Compute Earnings Headlines

Axe Compute Signs Penguin Solutions as Strategic Partner to Accelerate Delivery of Next-Generation AI Infrastructure as Demand for Axe Compute Build Surges
October 14 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/14/3380714/37244/en/axe-compute-signs-penguin-solutions-as-strategic-partner-to-accelerate-delivery-of-next-generation-ai-infrastructure-as-demand-for-axe-compute-build-surges.html
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
October 9, 2026  |  quiverquant.comQ
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
October 16 at 1:00 AM  |  Weiss Ratings (Ad)
Axe Compute Extends Georgia AI Cluster Contract Term
October 5, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/axe-compute-extends-georgia-ai-cluster-contract-term?utm_source=marketbeat.com&utm_medium=referral
Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract's Expected Free Cash Flow and Gross Margin
October 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/05/3374546/37244/en/axe-compute-takes-full-ownership-of-georgia-ai-cluster-significantly-increasing-the-contract-s-expected-free-cash-flow-and-gross-margin.html
Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call
September 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/29/3370841/37244/en/axe-compute-receives-more-than-184-million-in-customer-prepayments-and-signs-over-266-million-in-new-ai-infrastructure-contracts-since-q2-earnings-call.html
See More Axe Compute Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Axe Compute? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Axe Compute and other key companies, straight to your email.

About Axe Compute

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

View Axe Compute Profile
Earnings Tools